Sequential Intravesical Gemcitabine and Docetaxel for bacillus Calmette-Guérin-Naïve High-Risk Nonmuscle-Invasive Bladder CancerIan M. McElree, Vignesh T. Packiam, Ryan L. Steinberg et al.|The Journal of Urology|2022Cited by 71
Sequential Intravesical Valrubicin and Docetaxel for the Salvage Treatment of Non–Muscle-Invasive Bladder CancerIan M. McElree, Michael A. O’Donnell, Vignesh T. Packiam et al.|The Journal of Urology|2022Cited by 21
Reply by AuthorsIan M. McElree, Vignesh T. Packiam, Ryan L. Steinberg et al.|The Journal of Urology|2022Cited by 1
Multi-Institution Evaluation of Sequential Intravesical Gemcitabine and Docetaxel in the Treatment of Bacillus Calmette-Guerin Naïve Patients with Non-Muscle Invasive Bladder CancerLewis J. Thomas, Michael A. O’Donnell, Marcus J. Daniels et al.|Clinical Genitourinary Cancer|2022Cited by 1
PD26-03 SEQUENTIAL INTRAVESICAL GEMCITABINE AND DOCETAXEL FOR BCG-NAïVE HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCERIan M. McElree, Vignesh T. Packiam, Ryan L. Steinberg et al.|The Journal of Urology|2022Cited by 0